PODCAST

ADA 2021 18th July Questions Session 3

ADA 2021 18th July Questions Session 2

ADA 2021 18th July Questions Session 1

ADA 2021 11th July Questions Session 3

ADA 2021 11th July Questions Session 2

ADA 2021 11th July Questions Session 1

Practice-changing trials in Heart Failure and Kidney Disease with SGLT2 Inhibitors

Dr Deodatta Chafekar

Carbohydrate Counting : Still useful with New Technology?

Dr Vageesh Ayyar

Role of Telemedicine in the COVID-19 Era

Dr Arindam Ray

Evidence-based guidelines for Diabetes and Chronic Kidney Disease

Dr Abhijit Taraphdar

Learning to minimize risks for people with Diabetes in the COVID-19 Pandemic

Dr G. Shanmugan Sundar

Are we going to learn more from Broader Evaluations of new Glycemic Lowering Medications beyond CVO trials?

Dr Prabhaskar Dhorairaj

COVID 19 and Diabetes

Dr Arundhati Dasgupta

Intersection of Diabetes, Heart Failure and Kidney Disease

Dr S. Jayalakshmi

Are we there yet? Initiating SGLT2 Inhibitors in the Inpatient Cardiovascular Setting

Dr Jay Shah